Biophytis SA, 2026-09-23
A new SEC Form D private-offering notice from Paris, a $2,598,526 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biotech developing therapies for age related diseases, including a drug candidate for sarcopenia and obesity related mobility loss
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Seraxis Holdings, Inc., 2026-09-24, $10M, Germantown, MD
- Uvantis Therapeutics, Inc., 2026-09-23, $5M, Columbia, MD
- Caspian Therapeutics, Inc., 2026-09-23, $50M, San Diego, CA
- Navion Neurosciences Inc., 2026-09-22, $5.1M, Charlottesville, VA
- Opus Medical Therapies, LLC, 2026-09-22, Smyrna, GA
- Typewriter Therapeutics, Inc., 2026-09-21, $56.3M, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.